Literature DB >> 13489501

Phenmetrazine hydrochloride; a clinical evaluation of a new anoretic agent.

R FELDMAN, E C ALBERTON, L CRAIG.   

Abstract

Phenmetrazine hydrochloride appeared to be a safe anoretic agent and was effective in weight control in 80 per cent of a series of 49 obese patients. Tolerance to the drug did not develop in periods up to 18 weeks of continued treatment. Phenmetrazine was most effective in patients under 45 years of age in this series. Side effects were minimal and easily controlled. No allergic or toxic effects were noted.

Entities:  

Keywords:  OBESITY/therapy; SYMPATHOMIMETICS/therapeutic use

Mesh:

Substances:

Year:  1957        PMID: 13489501      PMCID: PMC1512205     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

1.  Phenmetrazine in the management of obesity.

Authors:  E P GELVIN; T H MCGAVACK; S KENIGSBERG
Journal:  Am J Dig Dis       Date:  1956-04

2.  Preludin (phenmetrazine) in the treatment of obesity.

Authors:  A MARTEL
Journal:  Can Med Assoc J       Date:  1957-01-15       Impact factor: 8.262

3.  Clinical evaluation of a new anorexic agent, phenmetrazine hydrochloride (preludin).

Authors:  A L NATENSHON
Journal:  Am Pract Dig Treat       Date:  1956-09

4.  [Various tetrahydro-1,4-oxazines with sympathomimetic properties].

Authors:  O THOMA; H WICK
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1954

5.  [Medicinal therapy of the obesity].

Authors:  K H BERNEIKE
Journal:  Med Klin       Date:  1954-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.